CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...
CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of...
Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) Treatment...
Rapid in vitro testing of repurposed drug candidates identified by Pharnext's PLEOTHERAPYTM Artificial Intelligence platformPARIS, France, 8:00am, April 22, 2020 (CET) - Pharnext SA...
Ideagen’s PleaseReview will improve review, co-authoring and redaction projects linked to cancer and other oncology treatments US-based pharmaceutical company, Immunomedics, is...
Researchers use big data analytics to find opportunities to help alleviate drug addiction amid the U.S. opioid crisis. Since 2004,...